Melbourne-based firm adds senior attorney with over 25 years of experience in therapeutics, diagnostics and biologics as demand for specialist patent services rises.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com
2 July 2026 The firm has appointed two new partners in Basel and Bristol, adding decades of expertise from the pharmaceutical and biotech sectors to its growing life sciences practice.
1 July 2026 A first-chair trial lawyer with two decades in high-stakes patent and trade secret disputes brings experience across medical devices, biologics, and pharmaceuticals, alongside a broader technology-focused practice.
30 June 2026 The latest additions bring experience representing technology and medical device companies in complex patent and commercial disputes, with the firm extending its run of bringing in partners from Winston & Strawn before its merger.